- Innoviz Technologies Ltd INVZ reported second-quarter FY21 revenue decline of 0.3% year-on-year to $1 million.
- The costs increased 23.8% Y/Y, leading to a gross loss of $(1.1) million.
- Operating expenses shot up 423.3% Y/Y due to $47.2 million attributable to stock-based compensation granted as part of the SPAC business combination, which closed in Q2 2021. Additionally, the company continued to invest heavily in R&D, with R&D expenses totaling $32.1 million.
- Loss per share was $(0.58), versus $(0.73) last year
- Innoviz held $351.4 million in cash and equivalents. It used $16.5 million in operating cash flow during Q2.
- Innoviz remains confident in its previously announced forward-looking order book guidance of $2.4 billion.
- Price Action: INVZ shares closed higher by 2.66% at $8.50 on Tuesday.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
